Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Accounts Receivable: ₽12.0 Mil (As of Dec. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIC:GEMA Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA
17 GF Score
Price ₽102.00
View Full Analysis

What is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Accounts Receivable?

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA +0.20% 17 Accounts Receivable is ₽12.0 Mil as of Dec. 2023. GuruFocus rates MIC:GEMA with a GF Score™ of 17/100.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's accounts receivables for the quarter that ended in Dec. 2023 was ₽12.0 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Days Sales Outstanding for the quarter that ended in Dec. 2023 was 15.67.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net-Net Working Capital per share for the quarter that ended in Dec. 2023 was ₽-42.18.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=12.04/70.132*91
=15.67

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's accounts receivable are only considered to be worth 75% of book value:

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(196.066+0.75 * 12.04+0.5 * 4.147-836.931
-0-0)/14.930
=-42.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Accounts Receivable Related Terms

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Accounts Receivable Chart

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
Get a 7-Day Free Trial 83.98 112.29 11.64 0.00 12.04

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.59 0.00 62.30 60.50 12.04
MIC:GEMA
17GF Score
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC MIC:GEMA
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of ₽12.0 Mil mean?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a Accounts Receivable of ₽12.0 Mil as of Dec. 2023. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Accounts Receivable too high?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current Accounts Receivable is ₽12.0 Mil. Overall, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Accounts Receivable compare to FICO and SPSC?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Accounts Receivable of ₽12.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Healthcare Providers & Services company?
A good Accounts Receivable depends on the Healthcare Providers & Services industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC and its competitors. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's current Accounts Receivable is ₽12.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC stock overvalued right now?
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) has a current Accounts Receivable of ₽12.0 Mil. The current Accounts Receivable is ₽12.0 Mil. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA), the current Accounts Receivable is ₽12.0 Mil as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Business Description

Address Ulitsa Gubkina, d. 3, Building 1, Floor 1, Moscow, RUS, 119333
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation, and Umbilical Cord tissue, among others.
17GF Score

Get the complete analysis for MIC:GEMA

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₽102.00
Price